phosphatidylcholines has been researched along with Coronary Artery Disease in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (6.90) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (37.93) | 29.6817 |
| 2010's | 11 (37.93) | 24.3611 |
| 2020's | 5 (17.24) | 2.80 |
| Authors | Studies |
|---|---|
| Arita, T; Fujino, T; Fukata, M; Kono, S; Maruyama, T; Mawatari, S | 1 |
| Bi, Y; Hou, T; Li, M; Lin, H; Lu, J; Ning, G; Wang, S; Wang, T; Wang, W; Xu, M; Xu, Y; Zhao, Z; Zheng, J | 1 |
| Heikkilä, ETM; Hilvo, M; Irjala, KM; Isoaho, RE; Jylhä, A; Katajamäki, TT; Kivelä, SL; Koivula, MK; Laaksonen, RMH; Lääperi, MTA; Löppönen, MK; Pulkki, KJ; Salminen, MJ; Viikari, L; Viljanen, AM | 1 |
| Aoyagi, R; Arita, M; Furuno, K; Hamase, K; Hara, T; Hirono, K; Kobayashi, T; Miyamoto, T; Mizuno, Y; Nakashima, Y; Nishio, H; Ohga, S; Onouchi, Y; Sakai, Y; Suzuki, H; Takada, H; Takatsuki, S; Tanabe, K; Tanaka, T; Yamamura, K | 1 |
| Brandtner, EM; Dopheide, JF; Drexel, H; Fraunberger, P; Jylhä, A; Kleber, M; Laaksonen, R; Lääperi, M; Leiherer, A; Mader, A; März, W; Mündlein, A; Ramadani, H; Säly, CH; Vonbank, A | 1 |
| Burggraaf, J; Jukema, JW; Kallend, DG; Malone, KE; Moerland, M; Reijers, JAA; Wijngaard, PLJ | 1 |
| Eha, J; Jakobson, M; Kals, J; Lieberg, J; Ottas, A; Paapstel, K; Piir, A; Tootsi, K; Zilmer, M | 1 |
| Bicker, W; Bochkov, VN; Erne, P; Oskolkova, OV; Philippova, M; Resink, TJ; Schoenenberger, AW | 1 |
| Cominacini, L; Fratta Pasini, A; Garbin, U; Mozzini, C; Pasini, A; Stranieri, C; Vallerio, P | 1 |
| Hornemann, T; Landmesser, U; Manz, J; Othman, A; Rentsch, K; Riwanto, M; Rohrer, L; Sutter, I; Velagapudi, S; von Eckardstein, A | 1 |
| Heg, D; Hornemann, T; Klingenberg, R; Landmesser, U; Lüscher, TF; Mach, F; Matter, CM; Othman, A; Rodondi, N; Rohrer, L; Sutter, I; von Eckardstein, A; Windecker, S | 1 |
| Asztalos, BF; Bellibas, SE; Jeyarajah, E; Kallend, DG; Kempen, HJ; Moerland, M; Otvos, J; Wijngaard, PL | 1 |
| Bellibas, SE; Bobillier, A; Burggraaf, J; Kallend, DG; Kempen, H; Moerland, M; Reijers, JA; Wijngaard, PL | 1 |
| Ivanova, EA; Melnichenko, AA; Orekhov, AN; Sobenin, IA; Sukhorukov, VN; Zakiev, ER | 1 |
| Calabresi, L; Gomaraschi, M; Jeyarajah, E; Kallend, D; Kempen, HJ; Moerland, M; Otvos, J; Simonelli, S; Wijngaard, PLJ | 1 |
| Bollinger, JG; Burgert, ME; Fenning, RS; Gelb, MH; Hamamdzic, D; Hoffman, BE; Li, J; Macphee, CH; Mirabile, RC; Mohler, ER; Pelchovitz, DJ; Postle, A; Shi, Y; Walker, MC; Webb, CL; Wilensky, RL; Yang, J; Zalewski, A; Zhang, L; Zhang, P | 1 |
| Kataoka, Y; Nicholls, SJ; Nissen, SE; Uno, K | 1 |
| Blankenship, JC; Cooper, CJ; Crowe, T; Eaton, GM; Grines, CL; Halpern, S; Kerensky, R; Lauer, MA; Nissen, SE; Schoenhagen, P; Sheldon, WS; Tsunoda, T; Tuzcu, EM; Yasin, M | 1 |
| Rader, DJ | 1 |
| Jacobson, EL; Jacobson, MK; Kim, H; Lacko, AG | 1 |
| Sirtori, CR | 1 |
| Nash, DT | 1 |
| Crowe, T; Kapadia, S; Nicholls, SJ; Nissen, SE; Schoenhagen, P; Sipahi, I; Tuzcu, EM | 1 |
| Basser, R; Berry, C; Grégoire, J; Guertin, MC; Heinonen, TM; Ibrahim, R; Kouz, S; L'Allier, PL; Lavoie, MA; Lespérance, J; Rodés-Cabau, J; Tardif, JC | 1 |
| Attia, N; Chaaba, R; Chanussot, F; Hamda, KB; Hammami, M; Hammami, S; Moulin, P; Nakbi, A; Smaoui, M | 1 |
| Higashi, Y; Itabe, H; Komatsu, R; Mori, M; Suzuki, K; Takano, T; Tsukamoto, Y; Ueda, M | 1 |
| Bogatskaia, LN; Korkushko, OV; Kotko, DN; Kovalenko, AN; Novikova, SN | 1 |
| Tseluĭko, VI | 1 |
3 review(s) available for phosphatidylcholines and Coronary Artery Disease
| Article | Year |
|---|---|
SGLT2 Inhibition, Choline Metabolites, and Cardiometabolic Diseases: A Mediation Mendelian Randomization Study.
Topics: Choline; Coronary Artery Disease; Diabetes Mellitus, Type 2; Genome-Wide Association Study; Glycine; Humans; Mendelian Randomization Analysis; Phosphatidylcholines; Polymorphism, Single Nucleotide; Risk Factors; Sodium-Glucose Transporter 2 Inhibitors | 2022 |
ETC-216 for coronary artery disease.
Topics: Animals; Anticholesteremic Agents; Apolipoprotein A-I; Cholesterol, HDL; Coronary Artery Disease; Evidence-Based Medicine; Humans; Phosphatidylcholines; Treatment Outcome | 2011 |
Cardiovascular risk beyond LDL-C levels. Other lipids are performers in cholesterol story.
Topics: Animals; Apolipoprotein A-I; Arteriosclerosis; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Humans; Hyperlipidemias; Hypertriglyceridemia; Life Style; Obesity; Phosphatidylcholines; Risk Factors; Treatment Outcome | 2004 |
7 trial(s) available for phosphatidylcholines and Coronary Artery Disease
| Article | Year |
|---|---|
MDCO-216 Does Not Induce Adverse Immunostimulation, in Contrast to Its Predecessor ETC-216.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Apolipoprotein A-I; C-Reactive Protein; Case-Control Studies; Coronary Artery Disease; Cytokines; Double-Blind Method; Drug Combinations; Female; Humans; Inflammation; Leukocyte Count; Male; Middle Aged; Phosphatidylcholines; Young Adult | 2017 |
High-Density Lipoprotein Subfractions and Cholesterol Efflux Capacities After Infusion of MDCO-216 (Apolipoprotein A-IMilano/Palmitoyl-Oleoyl-Phosphatidylcholine) in Healthy Volunteers and Stable Coronary Artery Disease Patients.
Topics: Anticholesteremic Agents; Apolipoprotein A-I; ATP Binding Cassette Transporter 1; Biomarkers; Blotting, Western; Case-Control Studies; Cholesterol; Coronary Artery Disease; Dose-Response Relationship, Drug; Drug Combinations; Electrophoresis, Gel, Two-Dimensional; Healthy Volunteers; High-Density Lipoproteins, Pre-beta; Humans; Infusions, Intravenous; Lipoproteins, HDL; Macrophages; Netherlands; Particle Size; Phosphatidylcholines; Proton Magnetic Resonance Spectroscopy; Time Factors; Treatment Outcome | 2016 |
A single infusion of MDCO-216 (ApoA-1 Milano/POPC) increases ABCA1-mediated cholesterol efflux and pre-beta 1 HDL in healthy volunteers and patients with stable coronary artery disease.
Topics: Adult; Aged; Apolipoprotein A-I; Apolipoproteins E; ATP Binding Cassette Transporter 1; Cholesterol; Coronary Artery Disease; Drug Combinations; Female; Healthy Volunteers; High-Density Lipoproteins, Pre-beta; Humans; Male; Middle Aged; Phosphatidylcholines; Phospholipids; Triglycerides | 2016 |
Persistent changes in lipoprotein lipids after a single infusion of ascending doses of MDCO-216 (apoA-IMilano/POPC) in healthy volunteers and stable coronary artery disease patients.
Topics: Animals; Apolipoprotein A-I; ATP Binding Cassette Transporter 1; Biomarkers; CD36 Antigens; Cell Line; Cholesterol Esters; Coronary Artery Disease; Dose-Response Relationship, Drug; Drug Combinations; Healthy Volunteers; Humans; Hypolipidemic Agents; Infusions, Intravenous; Lipoproteins; Macrophages; Mice; Phosphatidylcholines; Proton Magnetic Resonance Spectroscopy; Time Factors; Treatment Outcome | 2016 |
Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Angina, Unstable; Apolipoprotein A-I; Coronary Angiography; Coronary Artery Disease; Double-Blind Method; Female; Humans; Male; Middle Aged; Myocardial Infarction; Phosphatidylcholines; Prospective Studies; Ultrasonography, Interventional | 2003 |
Relationship between atheroma regression and change in lumen size after infusion of apolipoprotein A-I Milano.
Topics: Adult; Aged; Apolipoprotein A-I; Coronary Artery Disease; Coronary Vessels; Humans; Infusions, Intravenous; Male; Middle Aged; Phosphatidylcholines; Remission Induction; Ultrasonography, Interventional | 2006 |
Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial.
Topics: Aged; Angina, Unstable; Apolipoprotein A-I; Cardiovascular Agents; Cholesterol, HDL; Coronary Angiography; Coronary Artery Disease; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Phosphatidylcholines; Ultrasonography, Interventional | 2007 |
19 other study(ies) available for phosphatidylcholines and Coronary Artery Disease
| Article | Year |
|---|---|
Decreases of ethanolamine plasmalogen and phosphatidylcholine in erythrocyte are a common phenomenon in Alzheimer's, Parkinson's, and coronary artery diseases.
Topics: Alzheimer Disease; Coronary Artery Disease; Erythrocyte Membrane; Humans; Parkinson Disease; Phosphatidylcholines; Phosphatidylethanolamines; Plasmalogens; Sphingomyelins | 2022 |
Ceramides and Phosphatidylcholines Associate with Cardiovascular Diseases in the Elderly.
Topics: Aged; Cardiovascular Diseases; Ceramides; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Humans; Middle Aged; Phosphatidylcholines; Prospective Studies; Risk Factors; Stroke | 2022 |
Lipidomics links oxidized phosphatidylcholines and coronary arteritis in Kawasaki disease.
Topics: Adaptor Proteins, Signal Transducing; Arteritis; Biomarkers; Case-Control Studies; Child; Child, Preschool; Chromatography, Liquid; Coronary Artery Disease; Female; Humans; Japan; Lipidomics; Lipoproteins, LDL; Male; Mucocutaneous Lymph Node Syndrome; Oxidation-Reduction; Phenylalanine; Phosphatidylcholines; Prospective Studies; Scavenger Receptors, Class E; Tandem Mass Spectrometry | 2021 |
Lipid profiles of patients with manifest coronary versus peripheral atherosclerosis - Is there a difference?
Topics: Atherosclerosis; Ceramides; Coronary Artery Disease; Diabetes Mellitus, Type 2; Humans; Lipids; Lipoproteins; Peripheral Arterial Disease; Phosphatidylcholines; Risk Factors | 2021 |
Inverse relations of serum phosphatidylcholines and lysophosphatidylcholines with vascular damage and heart rate in patients with atherosclerosis.
Topics: Aged; Angiography, Digital Subtraction; Arginine; Biomarkers; Case-Control Studies; Coronary Artery Disease; Cross-Sectional Studies; Endothelium, Vascular; Heart Rate; Humans; Lysophosphatidylcholines; Male; Metabolomics; Middle Aged; Peripheral Arterial Disease; Phosphatidylcholines; Pulse Wave Analysis; Vascular Stiffness | 2018 |
Analysis of fragmented oxidized phosphatidylcholines in human plasma using mass spectrometry: Comparison with immune assays.
Topics: Adult; Biomarkers; Cholesterol; Chromatography, Liquid; Cohort Studies; Coronary Artery Disease; Creatinine; Dyslipidemias; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hypertension; Male; Middle Aged; Oxidation-Reduction; Phosphatidylcholines; Tandem Mass Spectrometry; Triglycerides | 2019 |
Increased endoplasmic reticulum stress and Nrf2 repression in peripheral blood mononuclear cells of patients with stable coronary artery disease.
Topics: Aged; Animals; Apoptosis; Coronary Artery Disease; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Female; Free Radicals; Gene Expression Regulation; Humans; Leukocytes, Mononuclear; Lipoproteins, LDL; Male; Middle Aged; NF-E2-Related Factor 2; Phosphatidylcholines; Transcription Factor CHOP; Unfolded Protein Response | 2014 |
Plasmalogens of high-density lipoproteins (HDL) are associated with coronary artery disease and anti-apoptotic activity of HDL.
Topics: Acute Coronary Syndrome; Adult; Aged; Apolipoprotein A-I; Apoptosis; Case-Control Studies; Chromatography, Liquid; Coronary Artery Disease; Discriminant Analysis; Endothelial Cells; Female; Humans; Least-Squares Analysis; Lipids; Lipoproteins, HDL; Lysophosphatidylcholines; Lysophospholipids; Male; Mass Spectrometry; Middle Aged; Phosphatidylcholines; Plasmalogens; Sphingomyelins; Sphingosine | 2015 |
Decreased phosphatidylcholine plasmalogens--A putative novel lipid signature in patients with stable coronary artery disease and acute myocardial infarction.
Topics: Aged; Biomarkers; Case-Control Studies; Chromatography, Liquid; Coronary Artery Disease; Female; Humans; Male; Mass Spectrometry; Middle Aged; Myocardial Infarction; Phosphatidylcholines; Plasmalogens; Predictive Value of Tests | 2016 |
Lipid composition of circulating multiple-modified low density lipoprotein.
Topics: Adult; Case-Control Studies; Cholesterol; Cholesterol Esters; Coronary Artery Disease; Female; Humans; Lipoproteins, LDL; Lysophosphatidylcholines; Male; Middle Aged; Phosphatidylcholines; Phosphatidylethanolamines; Sphingomyelins | 2016 |
Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Benzaldehydes; Coronary Artery Disease; Coronary Vessels; Enzyme Inhibitors; Gene Expression; Male; Oximes; Phosphatidylcholines; Swine | 2008 |
High-density lipoproteins as an emerging therapeutic target for atherosclerosis.
Topics: Apolipoprotein A-I; Coronary Artery Disease; Humans; Phosphatidylcholines | 2003 |
Synthetic HDL unclogs heart arteries. But until ETC-216 is approved, exercise and medication remain the best HDL boosters.
Topics: Apolipoprotein A-I; Cholesterol, HDL; Coronary Artery Disease; Exercise; Humans; Phosphatidylcholines | 2004 |
ApoA-1 Milano and regression of atherosclerosis.
Topics: Apolipoprotein A-I; Coronary Artery Disease; Humans; Lipoproteins, HDL; Phosphatidylcholines | 2004 |
ApoA-1 Milano and regression of atherosclerosis.
Topics: Animals; Apolipoprotein A-I; Coronary Artery Disease; Humans; Phosphatidylcholines | 2004 |
Increased phospholipid transfer protein activity associated with the impaired cellular cholesterol efflux in type 2 diabetic subjects with coronary artery disease.
Topics: Adult; Animals; Apolipoprotein A-I; Apolipoproteins B; Biological Transport; Carbon Radioisotopes; Carcinoma, Hepatocellular; Cell Line, Tumor; Cholesterol; Cholesterol, HDL; Cholesterol, VLDL; Coronary Artery Disease; Diabetes Mellitus, Type 2; Female; Humans; Liposomes; Liver Neoplasms, Experimental; Male; Middle Aged; Phosphatidylcholines; Phospholipid Transfer Proteins; Rats; Triglycerides | 2007 |
Lysosomal accumulation of oxidized phosphatidylcholine-apolipoprotein B complex in macrophages: intracellular fate of oxidized low density lipoprotein.
Topics: Animals; Apolipoproteins B; Cell Fractionation; Cell Line; Coronary Artery Disease; Foam Cells; Humans; Immunoblotting; Immunohistochemistry; Lipoproteins, LDL; Lysosomes; Macrophages; Mice; Phosphatidylcholines | 2000 |
[Correction of dyslipoproteinemia in middle-aged and elderly patients with atherosclerosis using Essentiale in combination with adebit].
Topics: Aged; Aged, 80 and over; Biguanides; Buformin; Coronary Artery Disease; Drug Evaluation; Drug Therapy, Combination; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Middle Aged; Phosphatidylcholines; Tablets; Time Factors | 1989 |
[Blood plasma prostanoids in coronary atherosclerosis patients].
Topics: Adult; Aged; Coronary Artery Disease; Drug Evaluation; Female; Hemoperfusion; Humans; Male; Middle Aged; Niacin; Phosphatidylcholines; Prostaglandins | 1986 |